LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients
NCT05058508 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2026-01-22
Summary
The purpose of this study is to see if there are physical and emotional benefits to participating in a structured exercise regimen for those who are ages 2-25, are newly diagnosed with a blood or solid tumor cancer, and are currently undergoing or will begin cancer treatment.
Conditions
- Pediatric Cancer
Interventions
- OTHER
-
"Just Move" Exercise
Subjects complete "Just Move" Exercises Five Times Per Week
- OTHER
-
Standard of Care Exercise
Subjects exercise/move as tolerated
Sponsors & Collaborators
-
Atrium Health Levine Cancer Institute
collaborator OTHER -
Wake Forest University Health Sciences
lead OTHER
Principal Investigators
-
Jennifer Pope, MD · Wake Forest University Health Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Years
- Max Age
- 25 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-11
- Primary Completion
- 2027-11-30
- Completion
- 2027-11-30
Countries
- United States
Study Locations
More Related Trials
-
Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics]
NCT03686566 ·Status: COMPLETED
-
Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in Children
NCT04659733 ·Status: UNKNOWN ·Phase: PHASE1
-
Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma
NCT00003793 ·Status: COMPLETED
-
Aerosol L9-NC and Temozolomide in Ewing's Sarcoma
NCT00492141 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma
NCT00003801 ·Status: COMPLETED ·Phase: NA
-
A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone
NCT01288573 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia
NCT01445080 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor
NCT00055952 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
NCT05634369 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.
NCT00560144 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors
NCT02756845 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study of SB939 in Pediatric Patients With Refractory Solid Tumours and Leukemia
NCT01184274 ·Status: COMPLETED ·Phase: PHASE1
-
Trabectedin and Irinotecan for Refractory Pediatric Sarcomas
NCT02509234 ·Status: UNKNOWN
-
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
NCT05734066 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study Protocol: Study on Incidence and Risk Factors of Mold Infections in Children During Leukemia Treatment
NCT05774990 ·Status: COMPLETED
-
Mobilization by Plerixafor of Haematopoietic Stem Cells in Children
NCT01225419 ·Status: COMPLETED ·Phase: PHASE2
-
Dissecting Tumour MicroenvirOnment in Solid Paediatric Tumour to Improve Adoptive Cell Therapy
NCT07240207 ·Status: RECRUITING
-
a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4
NCT00130858 ·Status: COMPLETED ·Phase: PHASE2
-
Exatecan Mesylate in Treating Children With Relapsed or Refractory Rhabdomyosarcoma
NCT00055939 ·Status: COMPLETED ·Phase: PHASE2
-
Panitumumab in Children With Solid Tumors
NCT00658658 ·Status: COMPLETED ·Phase: PHASE1
-
PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma
NCT01585649 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia
NCT06184009 ·Status: RECRUITING ·Phase: PHASE2
-
A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB
NCT01125800 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies
NCT01683149 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
NCT05135975 ·Status: RECRUITING ·Phase: PHASE2